Drug Study
Drug Study
Drug Study
Brand Name:
Dosage: 200mg 1 cap BID
Classification: Nonsteroidal Anti-Inflammatory Drugs
Indication: Treatment of osteoarthritis, pain, rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing
spondylitis. Reduction of the number of colorectal polyps.
Contraindication: Allergies to sulphonamides, celecoxib, NSAIDs, or aspirin; significant renal
impairment. Hypersensitivity to celecoxib and sulfonamides.
Mode of Action: Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor primarily responsible to
reduce mediators of pain and inflammation. Its action is due to inhibition of
prostaglandin synthesis via inhibition of COX-2.
Adverse Effects: Sinusitis, upper resp tract infection, UTI, allergy aggravated, insomnia, dizziness,
hypertonia, MI, pharyngitis, rhinitis, cough, dyspnoea, vomiting, diarrhoea, dyspepsia,
abdominal pain, flatulence, dysphagia, rash, pruritus, flu-like symptoms, peripheral
oedema/fluid retention, jaundice, liver necrosis
Nursing Responsibility: May be taken with or without meals. Advise patient to report signs or symptoms
of GI toxicity (abdominal pain, black stools) or hepatotoxicity (nausea, fatigue,
flu-like symptoms)